Literature DB >> 19616309

Lack of relationship between psychological denial and unawareness of illness in schizophrenia-spectrum disorders.

Carrie L Kruck1, Laura A Flashman, Robert M Roth, Nancy S Koven, Thomas W McAllister, Andrew J Saykin.   

Abstract

Numerous theories have been proposed to explain the unawareness of illness that is commonly seen in schizophrenia-spectrum disorders, including the theory that unawareness is the result of a psychological denial mechanism used to mitigate the emotional consequences of having a psychiatric illness. The present study was an attempt to determine whether increased denial (in the form of self-deception) is associated with impaired awareness, consistent with the denial theory. Participants included 40 patients with schizophrenia-spectrum disorders and 25 healthy comparison participants. Patients' levels of awareness and symptom attribution were assessed through interview, and all participants completed self-report questionnaires measuring mood symptoms as well as their use of self-deception. Awareness of negative symptoms was associated with increased depression. However, self-deception was not significantly correlated with awareness measures. When patients were divided on the basis of their awareness and attribution scores, no group differences emerged regarding use of self-deception. The patient group and the healthy comparison group did not differ in their use of self-deception. The current results do not support the psychological denial theory of unawareness of illness in schizophrenia-spectrum disorders.

Entities:  

Mesh:

Year:  2009        PMID: 19616309      PMCID: PMC2829772          DOI: 10.1016/j.psychres.2008.07.010

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  36 in total

1.  Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study.

Authors:  D A Regier; M E Farmer; D S Rae; B Z Locke; S J Keith; L L Judd; F K Goodwin
Journal:  JAMA       Date:  1990-11-21       Impact factor: 56.272

2.  Insight into current symptoms of schizophrenia. Association with frontal cortical function and affect.

Authors:  O Freudenreich; T Deckersbach; D C Goff
Journal:  Acta Psychiatr Scand       Date:  2004-07       Impact factor: 6.392

3.  Clinical symptomatology and drug compliance in schizophrenic patients.

Authors:  G Bartkó; I Herczeg; G Zádor
Journal:  Acta Psychiatr Scand       Date:  1988-01       Impact factor: 6.392

4.  Lack of insight: its status within schizophrenic psychopathology.

Authors:  V Peralta; M J Cuesta
Journal:  Biol Psychiatry       Date:  1994-10-15       Impact factor: 13.382

Review 5.  Poor insight in schizophrenia.

Authors:  X F Amador; D H Strauss
Journal:  Psychiatr Q       Date:  1993

6.  Insight and psychosocial treatment compliance in schizophrenia.

Authors:  P Lysaker; M Bell; R Milstein; G Bryson; J Beam-Goulet
Journal:  Psychiatry       Date:  1994-11       Impact factor: 2.458

7.  Insight and cognitive impairment in schizophrenia. Performance on repeated administrations of the Wisconsin Card Sorting Test.

Authors:  P Lysaker; M Bell
Journal:  J Nerv Ment Dis       Date:  1994-11       Impact factor: 2.254

8.  Assessment of insight in psychosis.

Authors:  X F Amador; D H Strauss; S A Yale; M M Flaum; J Endicott; J M Gorman
Journal:  Am J Psychiatry       Date:  1993-06       Impact factor: 18.112

9.  Awareness of illness in schizophrenia and schizoaffective and mood disorders.

Authors:  X F Amador; M Flaum; N C Andreasen; D H Strauss; S A Yale; S C Clark; J M Gorman
Journal:  Arch Gen Psychiatry       Date:  1994-10

10.  Effects of illness attribution and depression on the quality of life among persons with serious mental illness.

Authors:  D Mechanic; D McAlpine; S Rosenfield; D Davis
Journal:  Soc Sci Med       Date:  1994-07       Impact factor: 4.634

View more
  6 in total

1.  The National Alliance for Medical Image Computing, a roadmap initiative to build a free and open source software infrastructure for translational research in medical image analysis.

Authors:  Tina Kapur; Steve Pieper; Ross Whitaker; Stephen Aylward; Marianna Jakab; Will Schroeder; Ron Kikinis
Journal:  J Am Med Inform Assoc       Date:  2011-11-10       Impact factor: 4.497

2.  The Effects of Metacognition-Oriented Social Skills Training on Psychosocial Outcome in Schizophrenia-Spectrum Disorders: A Randomized Controlled Trial.

Authors:  Felix Inchausti; Nancy V García-Poveda; Alejandro Ballesteros-Prados; Javier Ortuño-Sierra; Sergio Sánchez-Reales; Javier Prado-Abril; José Antonio Aldaz-Armendáriz; Joe Mole; Giancarlo Dimaggio; Paolo Ottavi; Eduardo Fonseca-Pedrero
Journal:  Schizophr Bull       Date:  2018-10-17       Impact factor: 9.306

3.  Denial Defense Mechanism in Dialyzed Patients.

Authors:  Zbigniew Nowak; Zofia Wańkowicz; Krzysztof Laudanski
Journal:  Med Sci Monit       Date:  2015-06-22

4.  Illness denial questionnaire for patients and caregivers.

Authors:  Silvia Rossi Ferrario; Ines Giorgi; Paola Baiardi; Laura Giuntoli; Gianluigi Balestroni; Paola Cerutti; Marina Manera; Paola Gabanelli; Valentina Solara; Roberta Fornara; Michela Luisetti; Pierangela Omarini; Giovanna Omarini; Giulio Vidotto
Journal:  Neuropsychiatr Dis Treat       Date:  2017-03-23       Impact factor: 2.570

5.  Why Do Patients with Mental Disorders Default Treatment? A Qualitative Enquiry in Rural Kwazulu-Natal, South Africa.

Authors:  Kebogile Elizabeth Mokwena; Jabulile Ndlovu
Journal:  Healthcare (Basel)       Date:  2021-04-14

6.  The association between insight and depressive symptoms in schizophrenia: Undirected and Bayesian network analyses.

Authors:  Mario Amore; Martino Belvederi Murri; Pietro Calcagno; Paola Rocca; Alessandro Rossi; Eugenio Aguglia; Antonello Bellomo; Giuseppe Blasi; Bernardo Carpiniello; Alessandro Cuomo; Liliana dell'Osso; Massimo di Giannantonio; Giulia Maria Giordano; Carlo Marchesi; Palmiero Monteleone; Cristiana Montemagni; Lucio Oldani; Maurizio Pompili; Rita Roncone; Rodolfo Rossi; Alberto Siracusano; Antonio Vita; Patrizia Zeppegno; Alessandro Corso; Costanza Arzani; Silvana Galderisi; Mario Maj
Journal:  Eur Psychiatry       Date:  2020-05-06       Impact factor: 5.361

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.